To meet the logistics needs of today’s pharmaceutical and healthcare customers, it takes a carrier with a strong pharma background. And Swiss WorldCargo is the right carrier to do so. From providing a wide array of sophisticated, temperature controlled container solutions to leveraging the short tarmac times at Zurich airport, Swiss WorldCargo provides the right infrastructure, facilities and solutions to manage the most diverse requirements. 

Various Swiss WorldCargo products offer solutions that meet the wide-ranging needs of our pharmaceutical and healthcare customers. 

  • SWISS °Celsius Active allows for transportation in a wide range of active temperature-controlled containers in temperature ranges from -20 °C to +20 °C. 
  • SWISS °Celsius Passive offers a choice between four official IATA temperature ranges varying between -60°C and +25°C, alongside standardized processes ensuring the proper environment for storage. 
  • SWISS °Celsius Passive Solutions offers standardized processes to ensure that cargo is stored in a required temperature environment. Uninterrupted cool chain door-to-door is also ensured.
Go to article: Home | Taming the pharma beastGo to article: In this issueGo to article: Emirates SkyCargoGo to article: ContentsGo to article: TSS Company InsightGo to article: NewsGo to article: Daiichi JitsugyoGo to article: ICCI Company InsightGo to article: ICCIGo to article: The pharma industry briefingGo to article: Novo NordiskGo to article: Swiss WorldCargoGo to article: Understanding drug-resistant TBGo to article: CBDepot Company InsightGo to article: CBDepotGo to article: Through time: the breakthroughs that changed the course of HIV treatmentGo to article: Senn ChemicalsGo to article: Qatar AirwaysGo to article: Trouble at Teva: US price-fixing lawsuit adds to generic giant’s woesGo to article: Accurate Biometrics Company InsightGo to article: Accurate BiometricsGo to article: The dangers of unlicensed stem cell clinicsGo to article: Komtur PharmaceuticalsGo to article: How do cancer cells communicate and can it help us catch them?Go to article: Verona’s ensifentrine: a potentially revolutionary treatment for COPDGo to article: Taming the pharma monster with Hedley ReesGo to article: Capsugel Company InsightGo to article: Altheria SolutionsGo to article: ‘Pay As You Go’ AI for drug discoveryGo to article: AtoZ-CRO GmbHGo to article: PharmaHempGo to article: Event: CPhl KoreaGo to article: EventsGo to article: Centaur Clinical | Company InsightGo to article: Centaur ClinicalGo to article: Next issueGo to article: Hapa Company InsightGo to article: Pfanstiehl